— Know what they know.
Not Investment Advice

PVLA NASDAQ

Palvella Therapeutics, Inc.
1W: -4.1% 1M: -13.4% 3M: -5.6% YTD: +32.1% 1Y: +109.5%
$132.47
-0.26 (-0.20%)
 
Weekly Expected Move ±5.3%
$119 $126 $132 $139 $146
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $1.9B mcap · 10M float · 2.51% daily turnover · Short 47% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-62M
Net Income
-185.5% YoY
$-37M
Free Cash Flow
-107.5% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-46.6%
ROA-37.7%
ROIC137.5%

Valuation

P/E-27.4
P/B8.8
EV/EBITDA-38.9

Leverage

Debt/Equity0.00
Current Ratio21.18
Interest Cov.-7.9x

Quality Scores

Piotroski F3/9
Altman Z35.39
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms